secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001161697-26-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical prelim Q4 revenue $10.9M (+23% YoY); FY revenue $41.1M (+22% YoY); positive op cash flow
--------------------------------------------------------------------------------

- Preliminary Q4 2025 net revenue $10.9M, up 23% YoY; full year net revenue $41.1M, up 22% YoY.
- Ending cash balance $8.9M; positive cash flow from operations in Q4 and for full year.
- Submitted 510(k) for Freedom Infusion System for use with Phesgo, expanding into oncology.
- Company plans to release final 2025 results and 2026 guidance in early March 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000027/0001161697-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000027/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer